Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy

• Egile Nagusiak: Jianqiang Wu (Egilea), Qing Zhou (Egilea), Hua Zhou (Egilea), Meiping Lu (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2023-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Gain-of-function mutations in STING1 (also known as TMEM173) which result in constitutive activation of STING, have been reported to cause STING-associated vasculopathy with onset in infancy (SAVI). Although a wider spectrum of associated manifestations and perturbations in disea...